Sysmex Corporation announced the permission to manufacture and market HISCL -Amyloid 1-42 Assay Kit and the HISCL -Amyloid 1-40 Assay Kit in Japan. The Product uses the company's automated immunoassay system HISCL-5000/HISCL-800 (the "HISCL-Series") to measure A levels in the blood and help identify A buildup in the brain, a sign of Alzheimer's disease.
Biogen, Inc. along with Eisai Co., Ltd. Announced that approval of U.S. Food and Drug Administration for ADUHELM has been speed up. Moreover, in order to support access for all eligible patients, particularly for depressed- class of the populations, both the company created a number of programs. These programs seek to aid patients and their families in comprehending the illness, navigating the diagnosis process, obtaining culturally competent care, and managing the cost of treatment.
Author Credits: Radhika Gupta, Shivam Bhutani